Literature DB >> 31880161

Risk factors differentially associated with non-alcoholic fatty liver disease in males and females with metabolic syndrome.

María Vanessa Bullón Vela1, Itziar Abete2, María de Los Ángeles Zulet2, Josep A Tur3, Xavier Pintó4, Emili Corbella5, Miguel Ángel Martínez González6, Dolores Corella7, Manuel Macías González8, Francisco Tinahones8, Montserrat Fitó9, Ramón Estruch10, Emilio Ros11, Jordi Salas Salvadó12, Lidia Daimiel13, J Alfredo Martínez2.   

Abstract

BACKGROUND AND AIMS: non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in western countries. This study aimed to investigate putative risk factors differentially related with NAFLD in obese males and females diagnosed with metabolic syndrome (MetS), stratified using the non-invasive hepatic steatosis index (HSI). METHODS AND
RESULTS: a cross-sectional analysis of the PREDIMED Plus study was performed of 278 participants with MetS (141 males and 137 females) of the Navarra-Nutrition node. Subjects were categorized by HSI tertiles and gender. Baseline clinical, biochemical variants and adherence to a Mediterranean diet and physical activity were evaluated.
RESULTS: multivariate analyses showed that females had 4.54 more units of HSI (95% CI: 3.41 to 5.68) than males. Both sexes showed increased levels of triglycerides, TG/HDL cholesterol ratio and triglyceride glucose index across the HSI tertiles. Physical activity exhibited a negative statistical association with HSI (males: r = -0.19, p = 0.025; females: r = -0.18, p = 0.031). The amount of visceral fat showed a positive association with HSI in both sexes (males: r = 0.64, p < 0.001; females: r = 0.46, p < 0.001). Adherence to the Mediterranean diet was lower in those subjects with higher HSI values (males: r = -0.18, p = 0.032; females r= -0.19, p = 0.027).
CONCLUSION: females had a poor liver status, suggesting gender differences related to NAFLD. Adherence to a Mediterranean diet and physical activity were associated with beneficial effects on cardiovascular disease features. Thus, reducing the risk of hepatic steatosis in subjects with MetS and obesity.

Entities:  

Mesh:

Year:  2020        PMID: 31880161     DOI: 10.17235/reed.2019.6031/2018

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  2 in total

1.  Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model.

Authors:  Jesús Funuyet-Salas; Agustín Martín-Rodríguez; María Ángeles Pérez-San-Gregorio; Manuel Romero-Gómez
Journal:  J Clin Med       Date:  2021-05-20       Impact factor: 4.241

2.  Urinary Resveratrol Metabolites Output: Differential Associations with Cardiometabolic Markers and Liver Enzymes in House-Dwelling Subjects Featuring Metabolic Syndrome.

Authors:  Vanessa Bullón-Vela; Itziar Abete; Maria Angeles Zulet; Yifan Xu; Miguel A Martínez-González; Carmen Sayón-Orea; Miguel Ruiz-Canela; Estefanía Toledo; Vicente Martín Sánchez; Ramon Estruch; Rosa María Lamuela-Raventós; Enrique Almanza-Aguilera; Montserrat Fitó; Jordi Salas-Salvadó; Andrés Díaz-López; Francisco J Tinahones; Josep A Tur; Dora Romaguera; Jadwiga Konieczna; Xavier Pintó; Lidia Daimiel; Ana Rodriguez-Mateos; José Alfredo Martínez
Journal:  Molecules       Date:  2020-09-22       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.